Latest News

  • CRISPR Diagnostics, A Plan for Reagent Shortages, Community Testing: COVID-19 Updates

    Diagnostics World News | Stanford’s CRISPR-on-a-chip diagnostic, new diagnostic kit with DIY reagents, and recommendations to boost UK testing services. Plus, Oxford and Thermo Fisher join forces, Massachusetts school district plans weekly COVID-19 surveillance, and a new antibody test from EUROIMMUN.

    Nov 13, 2020
  • Test Strip Approach To Real-Time Cancer Tracking Moving Into Trials

    Diagnostics World NewsPhysicians could use a diagnostic device to aid clinical decision-making for patients with cancer and chronic diseases at the point of care (POC)—be that in the home, doctor’s office, or hospital emergency department.

    Nov 11, 2020
  • Fall News, Updates From Mammoth Biosciences, Rady Children’s, Genomenon, New England Biolabs, More

    Diagnostics World News | New products, collaborations and deployments from the past two months from Mammoth Biosciences, Scopio Labs, Caris Life Sciences, Rady Children’s, Genomenon, Thirona, the Society to Improve Diagnosis in Medicine, and more.

    Nov 10, 2020
  • SmartWatch Predicts SARS-CoV-2 Infection, Skin Reveals ‘Long Haulers’, Seven Forms Identified: COVID-19 Updates

    Diagnostics World News I Red marrow main target, increase in STIs amid lockdown, Dante Labs to offer Fluidigm’s saliva-based test, COVID-19 worsens tinnitus, few SNFs have fast test result turnaround time, University of Illinois creates successful test and trace program, yearlong study will determine seropositivity in frontline workers, myocarditis not as common as suspected, PerkinElmer receives EUA for pooled sample testing, and viral load determines outcomes with COVID-19 pneumonia. Plus: Twenty percent experience GI symptoms, 1.7 million New Yorkers infected, lung damage found in ‘long COVID’, unique case infectious for 70 days, and delirium early symptom in elderly.

    Nov 6, 2020
  • Organ-On-A-Chip Model For Monitoring Side Effects Of Chemotherapy

    Diagnostics World News | An international team of researchers has demonstrated that an organ-on-a-chip model can accurately measure the effects of a chemotherapeutic on breast cancer tissue and simultaneously identify the unintended side effects on healthy heart tissue.

    Nov 5, 2020
  • Image Analysis With AI-Enabled Privacy

    Diagnostics World News | Georgia State University faculty have received a five-year, $3 million federal grant to further develop a tool that will allow researchers around the world to participate in extensive brain imaging analysis without sharing protected patient data.

    Nov 4, 2020
  • Combination Tests Emerge to Tackle Potential “Twindemic”

    Diagnostics World News | As the coronavirus pandemic overlaps with flu season, some experts say early detection will be especially crucial for battling this double threat. And in recent months, new diagnostic tests have emerged to help distinguish one from the other.

    Nov 2, 2020
  • Cell-Free Antibody Test, Ultrasounds Show Cardiac Impact, Acuity Score Predicts Outcomes: COVID-19 Updates

    Diagnostics World News I Organs-on-Chips technology to evaluate potential vaccines, COVID-19 associated strokes, recovered patients may be asymptomatic carriers, metabolites identified as biomarkers, frontal lobe involvement in abnormal EEGs, and antibodies detectable for several months. Plus: AI-based algorithm predicts acute kidney injury, PerkinElmer screens for COVID-19 and flu in single test, faster more efficient antibody test by U-M scientists, and NYC outbreak linked to European strains of the virus.

    Oct 30, 2020
  • Follow the Money: New Diagnostics for Blood Infection, Dementia, Bone Disease

    Diagnostics World News | Australian company nets cash for finger-prick blood infection diagnostic, AI-powered, “semi-autonomous” bone image diagnostics platform, NIH grants for non-Alzheimer’s dementias, and more.

    Oct 28, 2020
  • ‘Danger Molecule’ Associated With Inflammation, Obesity And Subclinical Cardiovascular Risk—And May Correlate With COVID-19

    Diagnostics World News | It has been known for several years now that a “danger molecule” shows up in the blood when cells in the body are under stress or tissues are injured, inducing a potent inflammatory response—at least in rats. High Mobility Group Box-1 (HMGB1) is in fact one of the best characterized damage-associated molecular patterns.

    Oct 26, 2020